Investor profile
GlaxoSmithKline has backed 1 European tech company across 1 funding round in 2015, joining rounds totalling €59M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| CRISPR Therapeutics | Switzerland | 1 | €59M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| CRISPR Therapeutics | Series B | €59M | 2015-04 |
